A. Araszkiewicz, D. Zozulińska, M. Trepińska, et al., “Inflammatory Markers as Risk Factors for Microangiopathy in Type 1 Diabetic Patients on Functional Intensive Insulin Therapy from the Onset of the Disease,” Diabetes Research and Clinical Practice, Vol. 74, No. 2, 2006, pp. S43-S40.
 G. Assmann and H. Schulte, “The Prospective Cardiovascular Munster (PROCAM) Study: Prevelance of Hyperlipidemia in Persons with Hypertension and/or Diabetes Mellitus and the Relationship to Coronary Heart Disease,” American Heart Journal, Vol. 116, 1988, pp. 1713-1724.
 S. M. Haffner, M. P. Stern, H. P. Haruda, et al., “Cardiovascular Risk Factors in Confirmed Prediabetic Individuals: Does the Clock for Coronary Heart Disease Start Ticking before the Onset of Clinical Diabetes?,” The Journal of the American Medical Association, Vol. 263, 1990, pp. 2893-2898.
 M. Laakso, T. Ronnemaa, K. Py?r?l?, et al., “Atherosclerosis Vascular Disease and Its Risk Factors on Non-Insulin Dependent Diabetic and Non-Diabetic Subjects in Finland,” Diabetes Care, Vol. 11, 1988, pp. 449-463.
 J. Stamler, O. Vaccaro, J. D. Neaton, et al., ”The Multiple Risk Factor Intervention Trial Research Group. Diabetes and Other Risk Factors on Coronary Heart Disease and Mortality among Middle-Aged Diabetic Men: A General Population Study,” Diabetes Care, Vol. 16, 1993, pp. 434-444.
 M. P. Stern, J. K. Patterson, S. M. Haffner, et al., “Lack of Awareness and Treatment of Hyperlipidemia in Type-2 Diabetes in a Community Survey,” The Journal of the American Medical Association, Vol. 262, 1989, pp. 360-364.
 K. Kornerup, B. G. Nordestgaard, B. Feldt-Rasmussen, et al., “Increased Transvascular Low Density Lipoprotein Transport in Insulin Dependent Diabetes: A Mechanistic Model for Development of Atherosclerosis,” Atherosclerosis, Vol. 170, No. 1, 2003, pp. 163-168.
 D. P. Wade, B. L. Knight and A. K. Soutar, “Regulation of Low-Density-Lipoprotein-Receptor mRNA by Insulin in Human Hepatoma HepG2 Cells,” European Journal of Biochemistry, Vol. 181, No. 3, 1989, pp. 727-731.
 G. Ramakrishnan and N. C. Chandra, “Estradiol Regulates Insulin Dependent Stimulation of LDL-Receptor Expression in HepG2 Cells,” Indian Journal of Clinical Biochemistry, Vol. 21, No. 1, pp. 8-14.
 S. Swami, C. Sztalryd and F. B. Kraemer, “Effects of Streptozotocin-Induced Diabetes on Low Density Lipoprotein Receptor Expression in Rat Adipose Tissue,” Journal of Lipid Research, Vol. 37, 1996, pp. 229-236.
 L. Duvillard, F. Galland, E. Florentin, et al., “Cell surface Expression of LDL Receptor is Decreased in Type-2 Diabetic Patients and is Normalized by Insulin Therapy,” Diabetes Care, Vol. 26, No. 5, 2003, pp. 1540-1544.
 R. J. Havel, H. A. Eder and J. H. Bragdon, “The Distribution and Chemical Composition of Ultracentrifugally Separated Lipoprotein in Human Serum,” Journal of Clinical Investigation, Vol. 34, No. 9, 1955, pp. 1345-1353.
 G. Ramakrishnan, A. Rana, C. Das and N. C. Chandra, “Study of Low-Density Lipoprotein Receptor Regulation by Oral (Steroid) Contraceptives: Desogestrel, Levonor- gestrel and Ethinyl Estradiol in JEG-3 Cell Line and Placental Tissue,” Contraception, Vol. 76, 2007, pp. 297-305.
 M. M. Bradford, “A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye Binding,” Analytical Biochemistry, Vol. 72, 1976, pp. 248-254.
 D. C. Schwenke and T. E. Carew, “Initiation of Atherosclerotic Lesions in Cholesterol-Fed Rabbits, II: Selective Retention of LDL vs Selective Increases in LDL Permeability in Susceptible Sites of Arteries,” Arteriosclerosis, Vol. 9, 1989, pp. 908-918.
 K. D. O’Brian, M. D. Allen, T. O. McDonald, et al., “Vascular Cell Adhesion Molecule-1 is Expressed in Human Coronary Atherosclerotic Plaques: Implications for the Mode of Progression of Advanced Coronary Atherosclerosis,” Journal Clinical Investigation, Vol. 92, 1993, pp. 945-951.
 M. Richardson, S. Hadcock, M. DeReske, et al., “Increased Expression in Vivo of VCAM-1 and E-selectin by the Aortic Endothelium of Normolipidemic and Hyperlipidemic Rabbits,” Arteriosclerosis, Thrombosis and Vascular Biology, Vol. 14, 1994, pp. 760-769.
 M. Navab, J. A. Berliner, A. D. Watson, et al., “The Yin and Yang of Oxidation in the Development of the Fatty Streak. A Review Based on the George Lyman Duff Memorial Lecture,” Arteriosclerosis, Thrombosis and Vascular Biology, Vol. 16, No. 7, 1994, pp. 831-842.
 P. M. Henson and D. W. H. Riches, “Modulation of Macrophage Maturation by Cytokines and Lipid Mediators: A Potential Role in Resolution of Pulmonary Inflammation,” Annals of the New York Academy of Sciences, Vol. 725, 2006, pp. 298-308.
 Y. Liu, L. M. Hulten and O. Wiklund, “Macrophages Isolated from Human Atherosclerotic Plaques Produce IL-8, and Oxysterols may Have a Regulatory Function for IL-8 Production,” Arteriosclerosis, Thrombosis and Vascular Biology, Vol. 17, 1997, pp. 317-323.
 J. A. Maries, S. Dahesh, J. Haynes, et al., “Protein-Pro- tein Interaction Affinity Plays a Crucial Role in Controlling the sho1p-Mediated Signal Transduction Pathway in Yeast,” Molecular Cell, Vol. 14, 2004, pp. 813-823.